These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 19772931

  • 1. SM934, a water-soluble derivative of arteminisin, exerts immunosuppressive functions in vitro and in vivo.
    Hou LF, He SJ, Wang JX, Yang Y, Zhu FH, Zhou Y, He PL, Zhang Y, Yang YF, Li Y, Tang W, Zuo JP.
    Int Immunopharmacol; 2009 Dec; 9(13-14):1509-17. PubMed ID: 19772931
    [Abstract] [Full Text] [Related]

  • 2. Suppressive effect of a novel water-soluble artemisinin derivative SM905 on T cell activation and proliferation in vitro and in vivo.
    Wang JX, Tang W, Yang ZS, Wan J, Shi LP, Zhang Y, Zhou R, Ni J, Hou LF, Zhou Y, He PL, Yang YF, Li Y, Zuo JP.
    Eur J Pharmacol; 2007 Jun 14; 564(1-3):211-8. PubMed ID: 17349993
    [Abstract] [Full Text] [Related]

  • 3. A novel artemisinin derivative, 3-(12-beta-artemisininoxy) phenoxyl succinic acid (SM735), mediates immunosuppressive effects in vitro and in vivo.
    Zhou WL, Wu JM, Wu QL, Wang JX, Zhou Y, Zhou R, He PL, Li XY, Yang YF, Zhang Y, Li Y, Zuo JP.
    Acta Pharmacol Sin; 2005 Nov 14; 26(11):1352-8. PubMed ID: 16225758
    [Abstract] [Full Text] [Related]

  • 4. Periplocoside E, an effective compound from Periploca sepium Bge, inhibited T cell activation in vitro and in vivo.
    Zhu YN, Zhao WM, Yang YF, Liu QF, Zhou Y, Tian J, Ni J, Fu YF, Zhong XG, Tang W, Zhou R, He PL, Li XY, Zuo JP.
    J Pharmacol Exp Ther; 2006 Feb 14; 316(2):662-9. PubMed ID: 16204471
    [Abstract] [Full Text] [Related]

  • 5. Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation.
    Wang JX, Tang W, Shi LP, Wan J, Zhou R, Ni J, Fu YF, Yang YF, Li Y, Zuo JP.
    Br J Pharmacol; 2007 Mar 14; 150(5):652-61. PubMed ID: 17262016
    [Abstract] [Full Text] [Related]

  • 6. Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses.
    Hou LF, He SJ, Li X, Yang Y, He PL, Zhou Y, Zhu FH, Yang YF, Li Y, Tang W, Zuo JP.
    Arthritis Rheum; 2011 Aug 14; 63(8):2445-55. PubMed ID: 21484768
    [Abstract] [Full Text] [Related]

  • 7. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M, Guy R, Waldmann H, Glennie M, Alexander DR.
    Cell Immunol; 1998 May 01; 185(2):101-13. PubMed ID: 9636688
    [Abstract] [Full Text] [Related]

  • 8. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW, Liao CH, Ying C, Chang CJ, Lin CM.
    Clin Immunol; 2006 Apr 01; 119(1):21-31. PubMed ID: 16406844
    [Abstract] [Full Text] [Related]

  • 9. 7'-(3',4'-dihydroxyphenyl)-N-[(4-methoxyphenyl)ethyl]propenamide (Z23), an effective compound from the Chinese herb medicine Fissistigma oldhamii (Hemsl.) Merr, suppresses T cell-mediated immunity in vitro and in vivo.
    Hu XD, Zhong XG, Zhang XH, Zhang YN, Zheng ZP, Zhou Y, Tang W, Yang Y, Yang YF, Hu LH, Zuo JP.
    Life Sci; 2007 Dec 14; 81(25-26):1677-84. PubMed ID: 18022200
    [Abstract] [Full Text] [Related]

  • 10. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
    Kang H, Choi TW, Ahn KS, Lee JY, Ham IH, Choi HY, Shim ES, Sohn NW.
    J Ethnopharmacol; 2009 May 04; 123(1):6-14. PubMed ID: 19429332
    [Abstract] [Full Text] [Related]

  • 11. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R, Yssel H, de Vries JE.
    J Immunol; 1993 Jun 01; 150(11):4754-65. PubMed ID: 7684412
    [Abstract] [Full Text] [Related]

  • 12. (5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide analog mediates immunosuppressive effects in vitro and in vivo.
    Zhou R, Zhang F, He PL, Zhou WL, Wu QL, Xu JY, Zhou Y, Tang W, Li XY, Yang YF, Li YC, Zuo JP.
    Int Immunopharmacol; 2005 Dec 01; 5(13-14):1895-903. PubMed ID: 16275624
    [Abstract] [Full Text] [Related]

  • 13. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.
    Gieni RS, Yang X, Kelso A, Hayglass KT.
    Immunology; 1996 Jan 01; 87(1):119-26. PubMed ID: 8666423
    [Abstract] [Full Text] [Related]

  • 14. (5R)-5-hydroxytriptolide inhibits IFN-gamma-related signaling.
    Zhou R, Wang JX, Tang W, He PL, Yang YF, Li YC, Li XY, Zuo JP.
    Acta Pharmacol Sin; 2006 Dec 01; 27(12):1616-21. PubMed ID: 17112417
    [Abstract] [Full Text] [Related]

  • 15. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines.
    Harrop JA, Reddy M, Dede K, Brigham-Burke M, Lyn S, Tan KB, Silverman C, Eichman C, DiPrinzio R, Spampanato J, Porter T, Holmes S, Young PR, Truneh A.
    J Immunol; 1998 Aug 15; 161(4):1786-94. PubMed ID: 9712045
    [Abstract] [Full Text] [Related]

  • 16. Rapamycin or tacrolimus alone fails to resist cardiac allograft accelerated rejection mediated by alloreactive CD4(+) memory T cells in mice.
    Liang H, Liao C, Qi Z, Sha C, Xie B, Chen J, Xia J, Wang Y, Yao Q, Zhao Y.
    Transpl Immunol; 2010 Feb 15; 22(3-4):128-36. PubMed ID: 19755159
    [Abstract] [Full Text] [Related]

  • 17. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer.
    Mattner F, Fischer S, Guckes S, Jin S, Kaulen H, Schmitt E, Rüde E, Germann T.
    Eur J Immunol; 1993 Sep 15; 23(9):2202-8. PubMed ID: 8103745
    [Abstract] [Full Text] [Related]

  • 18. Th1 development of naive CD4+ T cells is inhibited by co-activation with anti-CD4 monoclonal antibodies.
    Goedert S, Germann T, Hoehn P, Koelsch S, Palm N, Rüde E, Schmitt E.
    J Immunol; 1996 Jul 15; 157(2):566-73. PubMed ID: 8752903
    [Abstract] [Full Text] [Related]

  • 19. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC, Curotto de Lafaille MA, Collet de Araujo Lima GM, de Almeida Abrahamsohn I.
    Cell Immunol; 1996 May 25; 170(1):41-53. PubMed ID: 8660798
    [Abstract] [Full Text] [Related]

  • 20. Humulus scandens exhibits immunosuppressive effects in vitro and in vivo by suppressing CD4(+) T cell activation.
    Feng J, Wu Y, Yang Y, Jiang W, Hu S, Li Y, Yang Y.
    Am J Chin Med; 2014 May 25; 42(4):921-34. PubMed ID: 25004883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.